You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》科倫博泰(06990.HK)稱有信心扭虧及吸引長期價值投資者
阿思達克 06-28 17:28
專注於研發抗體偶聯藥物(ADC)的抗體偶聯藥物明日(29日)起在港招股,首席財務官兼董事會秘書周澤表示,公司現時收入主要來自於許可合作協議的首付及里程碑付款,過去兩年虧損已有所收窄,預期隨著產品研發推進,可獲得更多里程碑款項及商業化收入,加上核心產品正式上市後將錄得銷售收入,因此估計未來整體虧損額會逐年減少,有信心最終可實現盈利。 問到於市況波動時期上市會否擔心對企業估值有影響,他指出,公司選擇上市時機是基於長期規劃,認為現時的發展階段、業務成熟度及管線推展進度等都是合適狀態,又強調短期波動屬正常現象,對香港市場有信心,亦相信隨著企業價值不斷增長,可吸引到對長期價值投資有興趣的股東加入。 是次招股引入5名基石投資者,當中包括母公司科倫藥業(002422.SZ)附屬。他認為可體現大股東對公司發展的信心,又稱基石投資只佔首次公開發售一少部分,對今次市場化發行有信心。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account